Schoeneck, Germany

Manfred Heinsch

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: E.s. Bio-Tech Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manfred Heinsch. Retrieved from https://idiyas.com/inventor/manfred-heinsch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manfred Heinsch - Innovator in Vascular Prosthesis Technology

Introduction: Manfred Heinsch is an inventor based in Schöneck, Germany. He is currently associated with E.S. Bio-Tech Limited, where he focuses on developing innovative solutions in the field of biotechnology. Although he has not yet been granted any patents, his work in vascular prosthesis technology shows great promise.

Latest Patent Applications: Manfred Heinsch's notable patent application is for a vascular prosthesis designed for connection to a natural cardiovascular system. This vascular prosthesis includes a volume chamber that exhibits a pressure-expansion behavior closely resembling that of a natural blood vessel under specific blood pressure conditions. The design features an elastic yarn made from silicone, wrapped with polyethylene terephthalate (PET), which enhances its functionality and adaptability.

Conclusion: Manfred Heinsch's contributions to the field of vascular prosthesis technology reflect his commitment to innovation and improvement in medical devices. His ongoing work at E.S. Bio-Tech Limited is expected to lead to significant advancements in this area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…